UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Local injection of infliximab in severe fistulating perianal Crohn’s disease: an open uncontrolled study

Techniques in coloproctology, 2011-12, Vol.15 (4), p.407-412

2011

Volltextzugriff (PDF)

PC.01.8 INCREASING INTEROBSERVER AGREEMENT ON IBD ENDOSCOPIC SCORING SYSTEMS: RESULTS FROM THE IGIBDENDO EDUCATIONAL PROGRAM

Digestive and liver disease, 2014-03, Vol.46, p.S4-S4

2014

Volltextzugriff (PDF)

Anti-tumour necrosis factor alpha (Infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients

Digestive and liver disease, 2002-09, Vol.34 (9), p.626-630

2002

Volltextzugriff (PDF)

Infliximab in the treatment of Crohn's disease: Predictors of response in an Italian multicentric open study

Digestive and liver disease, 2005-08, Vol.37 (8), p.577-583

2005

Volltextzugriff (PDF)

P224 Diagnostic delay in inflammatory bowel disease is not associated with difficult access to healthcare facilities: a clinical study on incidental cases

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i377-i377

2023

Volltextzugriff (PDF)

P.1.109: LOCAL INJECTION OF INFLIXIMAB AFTER SURGERY IN SEVERE FISTULATING PERIANAL CROHN'S DISEASE: LONG-TERM FOLLOW-UP

Digestive and liver disease, 2011, Vol.43, p.S184-S184

2011

Volltextzugriff (PDF)

P.1.222: MUCOSAL HEALING IN ANTI-TNF REFRACTORY/INTOLERANT CROHN'S DISEASE WITH THALIDOMIDE THERAPY

Digestive and liver disease, 2011, Vol.43, p.S221-S222

2011

Volltextzugriff (PDF)

OC.12.1 INTEROBSERVER AGREEMENT IN IBD SCORES REQUIRES EXPERTISE AND EDUCATION: PRELIMINARY RESULTS FROM AN ONGOING IG-IBD STUDY

Digestive and liver disease, 2012-03, Vol.44, p.S80-S81

2012

Volltextzugriff (PDF)

P.82 LOCAL INJECTION OF INFLIXIMAB IN SEVERE FISTULIZING PERIANAL CROHN'S DISEASE (CD): HEALING RATE AND LONG TERM RESULTS

Digestive and liver disease, 2010, Vol.42, p.S132-S132

2010

Volltextzugriff (PDF)

OC.07.3 ENDOSCOPIC DILATION OF CROHN'S DISEASE (CD) STRICTURES: RESULTS OF SCHEDULED OF RETREATMENT

Digestive and liver disease, 2010, Vol.42, p.S87-S87

2010

Volltextzugriff (PDF)

OC1.02.3 LOCAL INJECTION OF INFLIXIMAB IN THE POSTOPERATIVE SYMPTOMATIC RECURRENCE OF CROHN'S DISEASE

Digestive and liver disease, 2008, Vol.40, p.S12-S12

2008

Volltextzugriff (PDF)

OC.09.5 LONG-TERM EFFECTIVENESS OF USTEKINUMAB IN PATIENTS WITH REFRACTORY CROHN’S DISEASE: A MULTICENTER REALLIFE STUDY

Digestive and liver disease, 2021-09, Vol.53, p.S129

2021

Volltextzugriff (PDF)

AF.52 LONG-TERM OUTCOME OF ACUTE SEVERE ULCERATIVE COLITIS RESPONSIVE TO INTRAVENOUS STEROID: A MULTICENTER IG-IBD STUDY

Digestive and liver disease, 2021-09, Vol.53, p.S160

2021

Volltextzugriff (PDF)

P327 Long-term effectiveness of ustekinumab in refractory Crohn’s disease: an Italian multicenter real-life study

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S351-S352

2021

Volltextzugriff (PDF)

Infliximab in the treatment of severe ulcerative colitis: a follow-up study

European review for medical and pharmacological sciences, 2004-09, Vol.8 (5), p.235

2004

Volltextzugriff (PDF)

DOP34 Long-term outcome of Acute Severe Ulcerative Colitis responsive to intravenous steroid: A multicenter study of the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S072-S073

2021

Volltextzugriff (PDF)

P452 Increasing interobserver agreement on IBD endoscopic scoring systems: results from the IGIBDEndo educational program

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S254-S255

2014

Volltextzugriff (PDF)

P289 Concordance in IBD endoscopic scoring requires expertise and training: Preliminary results of an ongoing IG-IBD study

Journal of Crohn's and colitis, 2012-02, Vol.6, p.S125-S125

2012

Volltextzugriff (PDF)

Analysis of clinical course of postoperative recurrence in Crohn's disease of distal ileum

Digestive diseases and sciences, 1992-02, Vol.37 (2), p.215-219

1992

Volltextzugriff (PDF)

Prediction of surgery for obstruction in Crohn's ileitis: a study of 64 patients

Digestive diseases and sciences, 1987-12, Vol.32 (12), p.1363-1369

1987

Volltextzugriff (PDF)

Infliximab therapy for severe ulcerative colitis refractory to steroid therapy: Report of two cases

Digestive and liver disease, 2000-11, Vol.32, p.A123-A123

2000

Volltextzugriff (PDF)

71 PS Infliximab in the management of pouchitis complicated by fistulae

Digestive and liver disease, 2002-06, Vol.34, p.A94-A94

2002

Volltextzugriff (PDF)

Treatment of fistulas in Crohn's disease with infliximab anti-tumor necrosis factor antibodies

Digestive and liver disease, 2000-05, Vol.32, p.A8-A8

2000

Volltextzugriff (PDF)

Radiologic assessment of extent of ulcerative colitis in acute phase

Radiologia medica, 1992-06, Vol.83 (6), p.765-769

1992

Volltextzugriff (PDF)

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

The lancet. Gastroenterology & hepatology, 2022-04, Vol.7 (4), p.294-306

2022

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(25)

Sprache

Englisch
(24)
Italienisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Local injection of infliximab in severe fistulating perianal Crohn’s disease: an open uncontrolled study

PC.01.8 INCREASING INTEROBSERVER AGREEMENT ON IBD ENDOSCOPIC SCORING SYSTEMS: RESULTS FROM THE IGIBDENDO EDUCATIONAL PROGRAM

Anti-tumour necrosis factor alpha (Infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients

Infliximab in the treatment of Crohn's disease: Predictors of response in an Italian multicentric open study

P224 Diagnostic delay in inflammatory bowel disease is not associated with difficult access to healthcare facilities: a clinical study on incidental cases

P.1.109: LOCAL INJECTION OF INFLIXIMAB AFTER SURGERY IN SEVERE FISTULATING PERIANAL CROHN'S DISEASE: LONG-TERM FOLLOW-UP

P.1.222: MUCOSAL HEALING IN ANTI-TNF REFRACTORY/INTOLERANT CROHN'S DISEASE WITH THALIDOMIDE THERAPY

OC.12.1 INTEROBSERVER AGREEMENT IN IBD SCORES REQUIRES EXPERTISE AND EDUCATION: PRELIMINARY RESULTS FROM AN ONGOING IG-IBD STUDY

P.82 LOCAL INJECTION OF INFLIXIMAB IN SEVERE FISTULIZING PERIANAL CROHN'S DISEASE (CD): HEALING RATE AND LONG TERM RESULTS

OC.07.3 ENDOSCOPIC DILATION OF CROHN'S DISEASE (CD) STRICTURES: RESULTS OF SCHEDULED OF RETREATMENT

OC1.02.3 LOCAL INJECTION OF INFLIXIMAB IN THE POSTOPERATIVE SYMPTOMATIC RECURRENCE OF CROHN'S DISEASE

OC.09.5 LONG-TERM EFFECTIVENESS OF USTEKINUMAB IN PATIENTS WITH REFRACTORY CROHN’S DISEASE: A MULTICENTER REALLIFE STUDY

AF.52 LONG-TERM OUTCOME OF ACUTE SEVERE ULCERATIVE COLITIS RESPONSIVE TO INTRAVENOUS STEROID: A MULTICENTER IG-IBD STUDY

P327 Long-term effectiveness of ustekinumab in refractory Crohn’s disease: an Italian multicenter real-life study

Infliximab in the treatment of severe ulcerative colitis: a follow-up study

DOP34 Long-term outcome of Acute Severe Ulcerative Colitis responsive to intravenous steroid: A multicenter study of the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)

P452 Increasing interobserver agreement on IBD endoscopic scoring systems: results from the IGIBDEndo educational program

P289 Concordance in IBD endoscopic scoring requires expertise and training: Preliminary results of an ongoing IG-IBD study

Analysis of clinical course of postoperative recurrence in Crohn's disease of distal ileum

Prediction of surgery for obstruction in Crohn's ileitis: a study of 64 patients

Infliximab therapy for severe ulcerative colitis refractory to steroid therapy: Report of two cases

71 PS Infliximab in the management of pouchitis complicated by fistulae

Treatment of fistulas in Crohn's disease with infliximab anti-tumor necrosis factor antibodies

Radiologic assessment of extent of ulcerative colitis in acute phase

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

Suchergebnisse filtern